Literature DB >> 9781023

MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity), a novel syndrome: assignment of disease locus to xp21.1-p22.13.

R Steinmüller1, D Steinberger, U Müller.   

Abstract

A previously unrecognised X-chromosomal mental retardation syndrome is described. Clinical hallmarks are mental retardation, epileptic seizures, hypogonadism, and -genitalism, microcephaly and obesity. Life expectancy of patients is less than two years. Based on the major clinical symptoms this condition is referred to by the acronym MEHMO. Haplotype and two-point linkage analyses in a large three-generation family assign the disease locus to Xp21.1-p22.13, to a region that is flanked by CYBB and DXS365.

Entities:  

Mesh:

Year:  1998        PMID: 9781023     DOI: 10.1038/sj.ejhg.5200180

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  8 in total

Review 1.  Hypogonadism and neurological diseases.

Authors:  Abdulaziz Alsemari
Journal:  Neurol Sci       Date:  2013-01-05       Impact factor: 3.307

2.  EIF2S3 Mutations Associated with Severe X-Linked Intellectual Disability Syndrome MEHMO.

Authors:  Martina Skopkova; Friederike Hennig; Byung-Sik Shin; Clesson E Turner; Daniela Stanikova; Katarina Brennerova; Juraj Stanik; Ute Fischer; Lyndal Henden; Ulrich Müller; Daniela Steinberger; Esther Leshinsky-Silver; Armand Bottani; Timea Kurdiova; Jozef Ukropec; Olga Nyitrayova; Miriam Kolnikova; Iwar Klimes; Guntram Borck; Melanie Bahlo; Stefan A Haas; Joo-Ran Kim; Leda E Lotspeich-Cole; Daniela Gasperikova; Thomas E Dever; Vera M Kalscheuer
Journal:  Hum Mutat       Date:  2017-01-23       Impact factor: 4.878

3.  Immunologic phenotype of a child with the MEHMO syndrome.

Authors:  I Trochanová; D Staníková; M Škopková; K Haštová; D Gašperíková; J Staník; P Čižnár
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

4.  Expanding the phenotype of the recurrent truncating eIF2γ pathogenic variant p.(Ile465Serfs*4) identified in two brothers with MEHMO syndrome.

Authors:  Sofia Ygberg; Anna Lindstrand
Journal:  Clin Case Rep       Date:  2022-06-19

5.  Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism with glucose dysregulation.

Authors:  Louise C Gregory; Carolina B Ferreira; Sara K Young-Baird; Hywel J Williams; Magdalena Harakalova; Gijs van Haaften; Sofia A Rahman; Carles Gaston-Massuet; Daniel Kelberman; Waseem Qasim; Sally A Camper; Thomas E Dever; Pratik Shah; Iain C A F Robinson; Mehul T Dattani
Journal:  EBioMedicine       Date:  2019-03-14       Impact factor: 11.205

6.  MEHMO syndrome mutation EIF2S3-I259M impairs initiator Met-tRNAiMet binding to eukaryotic translation initiation factor eIF2.

Authors:  Sara K Young-Baird; Byung-Sik Shin; Thomas E Dever
Journal:  Nucleic Acids Res       Date:  2019-01-25       Impact factor: 19.160

7.  Novel pathogenic EIF2S3 missense variants causing clinically variable MEHMO syndrome with impaired eIF2γ translational function, and literature review.

Authors:  Urania Kotzaeridou; Sara K Young-Baird; Vanessa Suckow; Alexis G Thornburg; Matias Wagner; Inga Harting; Stine Christ; Tim Strom; Thomas E Dever; Vera M Kalscheuer
Journal:  Clin Genet       Date:  2020-09-04       Impact factor: 4.296

8.  Monogenic and syndromic diabetes due to endoplasmic reticulum stress.

Authors:  Stephen I Stone; Damien Abreu; Janet B McGill; Fumihiko Urano
Journal:  J Diabetes Complications       Date:  2020-05-08       Impact factor: 2.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.